These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 340872)

  • 21. Proteins of Newcastle disease virus. A comparison by partial protease digestion among the strains of different pathogenicity.
    Nagai Y; Hamaguchi M; Maeno K; Iinuma M; Matsumoto T
    Virology; 1980 Apr; 102(2):463-7. PubMed ID: 6989098
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.
    Jestin V; Cherbonnel M; Morin M; Guittet M; Bennejean G
    Arch Virol; 1989; 105(3-4):189-98. PubMed ID: 2751429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the assembly of the envelope of Newcastle disease virus.
    Nagai Y; Ogura H; Klenk H
    Virology; 1976 Feb; 69(2):523-38. PubMed ID: 1258360
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral glycoprotein metabolism as a target for antiviral substances.
    Klenk HD; Schwarz RT
    Antiviral Res; 1982 Sep; 2(4):177-90. PubMed ID: 6184015
    [No Abstract]   [Full Text] [Related]  

  • 25. Glycoproteins of Sendai virus: purification and antigenic analysis.
    Urata DM; Seto JT
    Intervirology; 1975-1976; 6(2):108-14. PubMed ID: 58850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipeptide antibodies for analysis of pathotype-specific variations in cleavage activation of the membrane glycoprotein precursors of Newcastle disease virus isolates in cultured cells.
    Gorman JJ; Hodder AN; Selleck PW; Hansson E
    J Virol Methods; 1992 Apr; 37(1):55-70. PubMed ID: 1572931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses.
    Schmidt MF
    Virology; 1982 Jan; 116(1):327-38. PubMed ID: 6278712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antigenic properties of NDV glycoproteins synthesized in the presence of 2-deoxy-d-glucose].
    Vasileva L; Neĭcheva I
    Vet Med Nauki; 1986; 23(5):29-36. PubMed ID: 3765372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity.
    Garten W; Berk W; Nagai Y; Rott R; Klenk HD
    J Gen Virol; 1980 Sep; 50(1):135-47. PubMed ID: 7441209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide.
    Garten W; Kohama T; Klenk HD
    J Gen Virol; 1980 Nov; 51(Pt 1):207-11. PubMed ID: 7463006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.
    Choppin PW; Scheid A
    Rev Infect Dis; 1980; 2(1):40-61. PubMed ID: 6994202
    [No Abstract]   [Full Text] [Related]  

  • 32. Paramyxovirus-induced platelet aggregation. Requirement for neuraminic acid receptors on platelets.
    Larke RP; Turpie AG; Scott S; Chernesky MA
    Lab Invest; 1977 Aug; 37(2):150-7. PubMed ID: 881779
    [No Abstract]   [Full Text] [Related]  

  • 33. A regular subunit pattern seen on non-infectious Newcastle disease virus particles.
    Russell PH; Almeida JD
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1023-31. PubMed ID: 6726184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of infectivity and pathogenicity of myxovirus. Brief review.
    Rott R
    Arch Virol; 1979; 59(4):285-98. PubMed ID: 378183
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serological studies of pigeon sera for antibodies against a paramyxovirus isolate and Newcastle disease virus following recovery from paramyxovirus infection and after vaccination with a live and dead vaccine].
    Baumbach B; Schneider J
    Dtsch Tierarztl Wochenschr; 1985 Mar; 92(3):90-2. PubMed ID: 3886349
    [No Abstract]   [Full Text] [Related]  

  • 36. [Degradation of the supercapsid viral protein in cells infected with various strains of the Newcastle disease virus and its correlation to virulence].
    Sklianskaia EI; Lipkind MA; Tsvetkova IV; Gribkova NV; Kaverin NV
    Vopr Virusol; 1974; (5):604-10. PubMed ID: 4439877
    [No Abstract]   [Full Text] [Related]  

  • 37. Gangliosides and N-glycoproteins function as Newcastle disease virus receptors.
    Ferreira L; Villar E; Muñoz-Barroso I
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2344-56. PubMed ID: 15313478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maturation of the hemagglutinin-neuraminidase and fusion glycoproteins of two biologically distinct strains of Newcastle disease virus.
    Smith GW; Schwalbe JC; Hightower LE
    Prog Clin Biol Res; 1980; 40():275-91. PubMed ID: 7454726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disappearance of neuraminidase and hemagglutinin activities in NDV-infected chick embryo cell monolayer culture treated with inhibitors of protein synthesis. Brief report.
    Lipkind MA; Tsvetkova IV
    Arch Gesamte Virusforsch; 1971; 35(2):303-7. PubMed ID: 5167620
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteolytic processing of animal virus proteins.
    Butterworth BE
    Curr Top Microbiol Immunol; 1977; 77():1-41. PubMed ID: 72634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.